FIRST IN CLASS FIXED COMBINATION QUINOLONE-NSAID FOR BACTERIAL CONJUNCTIVITIS (OPHTHALMOLOGY, OCULAR INFECTIONS, INFLAMMATION)

FIRST IN CLASS FIXED COMBINATION QUINOLONE-NSAID FOR BACTERIAL CONJUNCTIVITIS (OPHTHALMOLOGY, OCULAR INFECTIONS, INFLAMMATION)
Product Description

Game changer FDC with Levofloxacin, a fluoroquinolone with a broad spectrum of action and activity on bacteria (Gram+ and Gram-) most frequently implicated in ocular infections, and ketorolac, NSAID with powerful anti-inflammatory effect and analgesic effect. Phase II studies completed.

Please, contact us to receive more information and to discuss partnership on a global scale.

Presentation: eyedrop, 5ml.IP Protected

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.